Dun & Bradstreet DNB · Forecast & Analysis
- Dun & Bradstreet was taken private by Clearlake Capital at $9.15 per share in August 2025, so the shares at issue in the new securities class action no longer trade.
- The entire news flow is litigation: eight of nine notices are bearish, alleging misleading statements between May 13 and August 26, 2025 around the buyout.
- The lead-plaintiff deadline of November 10, 2026 is the single dated catalyst; expect more law-firm solicitations before it passes.
- No class has been certified and the allegations are unproven, so any liability remains contingent rather than established fact.
News situation · 6 items / 30 D
1 of 6 straight from the issuer or regulator
Outlook for Dun & Bradstreet
Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.
No price statement: there is no price data for this asset. Based on 6 news items.
What drives it
- The November 10, 2026 lead-plaintiff deadline, likely to draw a final wave of law-firm notices
- Post-deadline lead-counsel appointment or a motion to consolidate, which would show the litigation advancing
- Amended complaints detailing the merger-proxy allegations around the $9.15 price and Executive Chairman conflicts
What argues against it
- No class has been certified and the allegations are unproven, so any liability is contingent and unquantified
- Because the public float is gone, the notices carry reputational and former-holder risk rather than tradable price pressure
- Settlement or judgment outcomes affecting former holders remain uncertain over the coming months
- Heavy US macro schedule this week, including the jobs report shortly and CPI data in four days, sets the backdrop but has no fixed direction for a delisted name
Coming up
- US: Jobless claims
- US: EIA Crude Oil Stocks Change
- US: Producer prices · expected 0.4%, previous 0.7%
Economic data for DNB
Full calendarRecently released
- TodayUSDCPI y/y●●●Forecast 4.2%Previous 3.7%
- TodayUSDCore CPI m/m●●●Forecast 0.2%Previous 0.3%
- TodayUSDCPI●●●Forecast 338.683Previous 336.298
- TodayUSDCPI m/m●●●Forecast 0.5%Previous 0.6%
- TodayUSDCore CPI n.s.a. m/m●●●Previous 0.4%
- TodayUSDCore CPI●●●Forecast 339.796Previous 338.896
- TodayUSDCore CPI y/y●●●Forecast 2.8%Previous 2.6%
Coming up
- November 12, 2026USDInitial Jobless Claims●●●in 1 day
- November 12, 2026USDEIA Crude Oil Stocks Change●●●in 1 day
- November 13, 2026USDCore PPI m/m●●●Forecast 0.4%Previous 0.7%in 2 days
- November 13, 2026USDPPI m/m●●●Forecast 0.4%Previous 1.3%in 2 days
- November 17, 2026USDCore Retail Sales m/m●●●Forecast 0.7%Previous 0.9%in 6 days
- November 17, 2026USDRetail Sales m/m●●●Forecast 0.3%Previous 0.8%in 6 days
All times UTC. Assessed against the consensus forecast, otherwise against the previous value.
Both worlds over time
Technical and news signals of the last 30 days on one timeline.
What is being reported about DNB
In-depth analysis of Dun & Bradstreet
AI-generated · as of November 6, 2026
Dun & Bradstreet is no longer a stock you can trade. The Clearlake Capital buyout closed on August 26, 2025 at $9.15 per share, removing the public float, and what remains is a legal-overhang story for former holders rather than a live market price.
Read full analysis
The bearish picture rests entirely on news sentiment, since there are no chart signals to weigh. Every recent notice concerns a securities fraud class action alleging that statements made between May 13, 2025 and the merger close were materially false and misleading. Rosen Law Firm and Robbins LLP are both soliciting lead plaintiffs, which points to parallel suits rather than one consolidated case, and the freshest notice adds proxy-specific claims: omitted valuations of supposedly superior alternatives, downward-revised projections, and conflicts involving the Executive Chairman. The lead-plaintiff deadline falls on November 10, 2026, days away, so a cluster of filings is likely first; after that, attention shifts to lead-counsel appointment and any amended complaint. One caution runs through all of this: the allegations are unproven, no class exists yet, and because the shares are delisted the litigation carries reputational weight rather than tradable price pressure. The strength of the bearish label here reflects consistent, moderate-conviction legal headlines, not selling pressure on a listed stock. For anyone who held shares before the merger, the class period and deadline are the facts that matter; for market watchers, this is now a private-company litigation story.
Frequently asked questions about Dun & Bradstreet
Can I still buy or sell Dun & Bradstreet shares?
No. The company was taken private by Clearlake Capital at $9.15 per share on August 26, 2025, so the public shares no longer trade. That is why the bearish picture here reflects litigation headlines rather than market prices, and why chart signals are absent. Anyone who held shares before the merger may still have an interest in the class action, but there is no public market left to enter or exit.
What does the class action actually allege?
The suit, pursued by firms including Rosen Law Firm and Robbins LLP, alleges that the company issued materially false and misleading statements between May 13, 2025 and August 26, 2025, the window ending with the merger close. The newest notice adds claims that the merger proxy omitted valuations of supposedly superior alternatives and downward-revised projections, and points to conflicts involving the Executive Chairman. None of this has been proven and no class has been certified yet.
Why is the November 10, 2026 deadline important?
That is the lead-plaintiff deadline, the date by which investors who want to lead the class action must put themselves forward. Expect a final cluster of law-firm solicitations before it passes. Afterward, the case moves to appointing lead counsel and possibly amending the complaint, which would show the litigation is genuinely advancing rather than just being marketed by plaintiff firms.
What would change this bearish picture?
A dismissal of the suit, a consolidation that narrows the allegations, or an early settlement without admitted wrongdoing would soften the legal overhang. Conversely, class certification, an amended complaint with more specific claims about the $9.15 price or Executive Chairman conflicts, or a large settlement demand would deepen the bearish narrative. Since the shares are delisted, these developments matter chiefly to former holders and to Clearlake's post-close exposure.
📝 Overview Generated automatically
DNB has been the subject of 9 signals across 9 articles in the last 365 days. Sentiment skews Bearish (89%).
Breakdown: 0 bullish, 8 bearish, 1 neutral.
Most-cited catalysts: Initiation of a securities fraud class action lawsuit (1×), Potential discovery of financial misrepresentations during the class period (1×), Initiation of class action litigation by Robbins LLP (1×). Most-cited risk factors: Potential for significant legal settlements or judgments (2×), Potential for significant financial penalties or settlements resulting from the lawsuit (1×), Negative impact on investor sentiment and stock price volatility (1×).